Melazyme is a biotech firm using microbial fermentation to produce high-purity melanin and protein sweeteners.
Melazyme has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Melazyme's investors include Plug and Play, Stellaris Venture Partners, SeaX Ventures.
Melazyme is headquartered in Holladay, United States.
Melazyme is a biotech firm using microbial fermentation to produce high-purity melanin and protein sweeteners.
Melazyme is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Melazyme — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/melazyme. Accessed October 31, 2026.
VCBacked. (2026). Melazyme — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/melazyme
{{cite web |title=Melazyme — Funding & Investors |url=https://www.vcbacked.co/company/melazyme |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated